Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Euitae Kim

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
The Lancet. Psychiatry|September 22, 2023
Associations between post-traumatic stress disorders and psychotic symptom severity in adult survivors of developmental trauma: a multisite cross-sectional study in the UK and South KoreaAva J C Mason, Paul Jung, Seoyoung Kim, et al.
Scientific Reports|November 5, 2017
Acute induction of anxiety in humans by delta-9-tetrahydrocannabinol related to amygdalar cannabinoid-1 (CB1) receptorsSagnik Bhattacharyya, Alice Egerton, Euitae Kim, et al.
Psychiatry Investigation|December 5, 2013
The impact of personality traits on ratings of obsessive-compulsive symptomsMin Jung Huh, Geumsook Shim, Min Soo Byun, et al.
Psychological Medicine|November 22, 2018
Frontostriatal functional connectivity and striatal dopamine synthesis capacity in schizophrenia in terms of antipsychotic responsiveness: an [<sup>18</sup>F]DOPA PET and fMRI studySeoyoung Kim, Wi Hoon Jung, Oliver D Howes, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 19, 2016
Presynaptic Dopamine Capacity in Patients with Treatment-Resistant Schizophrenia Taking Clozapine: An [<sup>18</sup>F]DOPA PET StudyEuitae Kim, Oliver D Howes, Mattia Veronese, et al.
International Clinical Psychopharmacology|August 11, 2011
What is the optimal dose of escitalopram for the treatment of obsessive-compulsive disorder? A naturalistic open-label studyGeumsook Shim, Hye Youn Park, Joon Hwan Jang, et al.
Schizophrenia Research|May 13, 2014
Symptomatic and functional remission of subjects at clinical high risk for psychosis: a 2-year naturalistic observational studyTae Young Lee, Sung Nyun Kim, Christoph U Correll, et al.
Human Psychopharmacology|September 19, 2006
Effects of DRD2 and CYP2D6 genotypes on delta EEG power response to aripiprazole in healthy male volunteers: a preliminary studyEuitae Kim, Kyung-Sang Yu, Joo-Youn Cho, et al.
Psychiatry Investigation|July 29, 2022
The Relationship Between Frontostriatal Connectivity and Striatal Dopamine Function in Schizophrenia: An 18F-DOPA PET and Diffusion Tensor Imaging Study in Treatment Responsive and Resistant PatientsSangho Shin, Wi Hoon Jung, Robert McCutcheon, et al.
Clinical Pharmacokinetics|August 26, 2016
Regional Differences in Serotonin Transporter Occupancy by Escitalopram: An [<sup>11</sup>C]DASB PK-PD StudyEuitae Kim, Oliver D Howes, Bo-Hyung Kim, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
The Lancet. Psychiatry|September 22, 2023
Associations between post-traumatic stress disorders and psychotic symptom severity in adult survivors of developmental trauma: a multisite cross-sectional study in the UK and South KoreaAva J C Mason, Paul Jung, Seoyoung Kim, et al.
Scientific Reports|November 5, 2017
Acute induction of anxiety in humans by delta-9-tetrahydrocannabinol related to amygdalar cannabinoid-1 (CB1) receptorsSagnik Bhattacharyya, Alice Egerton, Euitae Kim, et al.
Psychiatry Investigation|December 5, 2013
The impact of personality traits on ratings of obsessive-compulsive symptomsMin Jung Huh, Geumsook Shim, Min Soo Byun, et al.
Psychological Medicine|November 22, 2018
Frontostriatal functional connectivity and striatal dopamine synthesis capacity in schizophrenia in terms of antipsychotic responsiveness: an [<sup>18</sup>F]DOPA PET and fMRI studySeoyoung Kim, Wi Hoon Jung, Oliver D Howes, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 19, 2016
Presynaptic Dopamine Capacity in Patients with Treatment-Resistant Schizophrenia Taking Clozapine: An [<sup>18</sup>F]DOPA PET StudyEuitae Kim, Oliver D Howes, Mattia Veronese, et al.
International Clinical Psychopharmacology|August 11, 2011
What is the optimal dose of escitalopram for the treatment of obsessive-compulsive disorder? A naturalistic open-label studyGeumsook Shim, Hye Youn Park, Joon Hwan Jang, et al.
Schizophrenia Research|May 13, 2014
Symptomatic and functional remission of subjects at clinical high risk for psychosis: a 2-year naturalistic observational studyTae Young Lee, Sung Nyun Kim, Christoph U Correll, et al.
Human Psychopharmacology|September 19, 2006
Effects of DRD2 and CYP2D6 genotypes on delta EEG power response to aripiprazole in healthy male volunteers: a preliminary studyEuitae Kim, Kyung-Sang Yu, Joo-Youn Cho, et al.
Psychiatry Investigation|July 29, 2022
The Relationship Between Frontostriatal Connectivity and Striatal Dopamine Function in Schizophrenia: An 18F-DOPA PET and Diffusion Tensor Imaging Study in Treatment Responsive and Resistant PatientsSangho Shin, Wi Hoon Jung, Robert McCutcheon, et al.
Clinical Pharmacokinetics|August 26, 2016
Regional Differences in Serotonin Transporter Occupancy by Escitalopram: An [<sup>11</sup>C]DASB PK-PD StudyEuitae Kim, Oliver D Howes, Bo-Hyung Kim, et al.
Pageof 8